Probi AB Stock

Equities

PROB

SE0001280355

Pharmaceuticals

Real-time Estimate Cboe Europe 10:51:08 2024-04-25 am EDT 5-day change 1st Jan Change
208.5 SEK +1.71% Intraday chart for Probi AB -7.24% +0.99%
Sales 2024 * 654M 60.27M Sales 2025 * 699M 64.42M Capitalization 2.34B 215M
Net income 2024 * 15M 1.38M Net income 2025 * 32M 2.95M EV / Sales 2024 * 3.03 x
Net cash position 2024 * 355M 32.72M Net cash position 2025 * 397M 36.59M EV / Sales 2025 * 2.77 x
P/E ratio 2024 *
153 x
P/E ratio 2025 *
73.5 x
Employees -
Yield 2024 *
0.73%
Yield 2025 *
0.95%
Free-Float 28.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.20%
1 week-7.24%
Current month-2.84%
1 month+3.80%
3 months+0.99%
6 months+0.49%
Current year+0.99%
More quotes
1 week
199.00
Extreme 199
220.00
1 month
198.50
Extreme 198.5
224.00
Current year
181.00
Extreme 181
239.00
1 year
171.50
Extreme 171.5
239.00
3 years
165.00
Extreme 165
660.00
5 years
139.20
Extreme 139.2
660.00
10 years
39.90
Extreme 39.9
660.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 22-03-31
Director of Finance/CFO 58 Oct. 31
Director/Board Member 44 13-12-31
Members of the board TitleAgeSince
Director/Board Member 53 20-05-12
Chairman 60 15-03-31
Director/Board Member 62 17-05-03
More insiders
Date Price Change Volume
24-04-25 205 0.00% 589
24-04-24 205 +0.49% 292
24-04-23 204 0.00% 114
24-04-22 204 -1.45% 795
24-04-19 207 -6.33% 1,948

Delayed Quote Nasdaq Stockholm, April 25, 2024 at 03:00 am EDT

More quotes
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings